E2FBP1/hDril1 modulates cell growth through downregulation of promyelocytic leukemia bodies

19Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Promyelocytic leukemia nuclear bodies (PML-NBs) comprise multiple regulatory factors and play crucial roles in the maintenance of cellular integrity, while unregulated activation of PML-NBs induces death and premature senescence. Hence, the function of PML-NBs must be directed properly; however, the mechanism that regulates PML-NBs remains unclear. In this paper, we show that PML-NBs are disintegrated by an AT-rich interaction domain family protein E2FBP1/hDril1 through specific desumoylation of promyelocytic leukemia protein (PML) in vivo and in vitro. RNA interference-mediated downregulation of E2FBP1/hDril1 results in hyperplasis of PML-NBs and consequent commitment to PML-dependent premature senescence. Thus, the function of E2FBP1/hDril1 is required for maintenance of survival potential of the cells. Our data suggest a novel mechanism to govern cellular integrity through the modulation of nuclear depots. © 2004 Nature Publishing Group All rights reserved.

Cite

CITATION STYLE

APA

Fukuyo, Y., Mogi, K., Tsunematsu, Y., & Nakajima, T. (2004). E2FBP1/hDril1 modulates cell growth through downregulation of promyelocytic leukemia bodies. Cell Death and Differentiation, 11(7), 747–759. https://doi.org/10.1038/sj.cdd.4401412

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free